Literature DB >> 33928884

Long-acting injectable antipsychotics: what, when, and how - Addendum.

Leslie Citrome.   

Abstract

Year:  2021        PMID： 33928884     DOI： 10.1017/S1092852921000456

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  5 in total

1.  Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.

Authors:  Ethel D Weld; Jacqueline Astemborski; Gregory D Kirk; Mark S Sulkowski; Stephanie Katz; Richard Rothman; Sunil S Solomon; Gail V Matthews; Yu Hsiang Hsieh; Malvika Verma; Giovanni Traverso; Susan Swindells; Andrew Owen; Jordan Feld; Charles Flexner; Shruti H Mehta; David L Thomas
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study.

Authors:  Leslie Citrome; Emily Belcher; Sylvie Stacy; Mark Suett; Marko Mychaskiw; Gregory D Salinas
Journal:  Patient Prefer Adherence       Date:  2022-01-21       Impact factor: 2.711

3.  Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia.

Authors:  Alex Z Fu; Jacqueline A Pesa; Susan Lakey; Carmela Benson
Journal:  BMC Psychiatry       Date:  2022-04-09       Impact factor: 3.630

4.  Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians.

Authors:  Leslie Citrome; Emily Belcher; Sylvie Stacy; Mark Suett; Marko Mychaskiw; Gregory D Salinas
Journal:  Neuropsychiatr Dis Treat       Date:  2022-01-26       Impact factor: 2.570

5.  Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN).

Authors:  Petru Ifteni; Paula-Simina Petric; Andreea Teodorescu
Journal:  Front Psychiatry       Date:  2021-12-07       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.